Abstract
Introduction and epidemiologyThe prevalence of heart valve disease is progressively increasing mainly due to its degenerative etiology and the increase in expectancy of life in the general population. Prognosis and diagnosisModerate and severe mitral regurgitation (MI) worsen patients’ prognosis regardless of the mechanism responsible and the left ventricle systolic function. A higher index of clinical suspicion and routine cardiac auscultation followed by echocardiography are key tools for early diagnosis, even among asymptomatic patients. TreatmentMitral surgery is the main treatment for MI. In the last years, percutaneous procedures such as edge-to-edge transcatheter repair have been developed to treat a wider spectrum of patients. Despite the high mortality of patients with significant untreated MI, the reality is that MI is a clearly undertreated entity. ConclusionsThere are points of improvement along the flow followed by the patient with MI. Raising awareness among the population, improving early diagnosis and always seeking the best treatment are strategies that can lead to optimizing the management of patients with MI.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
